Compensatory weight gain due to dopaminergic hypofunction: new evidence and own incidental observations
Open Access
- 1 January 2008
- journal article
- research article
- Published by Springer Nature in Nutrition & Metabolism
- Vol. 5 (1) , 35
- https://doi.org/10.1186/1743-7075-5-35
Abstract
There is increasing evidence for a role of dopamine in the development of obesity. More specifically, dopaminergic hypofunction might lead to (over)compensatory food intake. Overeating and resulting weight gain may be induced by genetic predisposition for lower dopaminergic activity, but might also be a behavioral mechanism of compensating for decreased dopamine signaling after dopaminergic overstimulation, for example after smoking cessation or overconsumption of high palatable food. This hypothesis is in line with our incidental finding of increased weight gain after discontinuation of pharmaceutical dopaminergic overstimulation in rats. These findings support the crucial role of dopaminergic signaling for eating behaviors and offer an explanation for weight-gain after cessation of activities associated with high dopaminergic signaling. They further support the possibility that dopaminergic medication could be used to moderate food intake.Keywords
This publication has 29 references indexed in Scilit:
- Relation Between Obesity and Blunted Striatal Response to Food Is Moderated by Taq IA A1 AlleleScience, 2008
- Effects of intravenous glucose on dopaminergic function in the human brain in vivoSynapse, 2007
- Different levodopa actions on the extracellular dopamine pools in the rat striatumSynapse, 2006
- PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeysNature Neuroscience, 2006
- Does l-dopa treatment contribute to reduction in body weight in elderly patients with Parkinson's disease?Acta Neurologica Scandinavica, 2005
- H1-histamine Receptor Affinity Predicts Short-term Weight Gain for Typical and Atypical Antipsychotic DrugsNeuropsychopharmacology, 2003
- Applying genetic approaches to the treatment of nicotine dependenceOncogene, 2002
- Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokersSynapse, 2001
- Effects of phentermine on striatal dopamine and serotonin release in conscious rats:In vivo microdialysis studyInternational Journal of Obesity, 1998
- Modulatory effects of L-DOPA on D2 dopamine receptors in rat striatum, measured using in vivo microdialysis and PETJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998